drugset / Trial / NCT00635713
Second Line Breast Cancer Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to compare the effect of 2 doses of FASLODEX with 1 dose of ARIMIDEX in terms of time to tumor progression in postmenopausal women with advanced breast cancer.
Timeline
- Start
- 1997-05
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | — |
| Subject | Fulvestrant | Small molecule | 125 mg | — |
| Subject | Fulvestrant | Small molecule | 250 mg | — |